Search
Metabolic dysfunction–associated steatotic liver disease (MASLD) is a liver condition characterized by fat accumulation in the liver linked to metabolic risk factors such as obesity, type 2 diabetes, and insulin resistance.
From newborns to older adults, liver health is under threat and this summer we’re focusing on three key areas that urgently need your help: obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), living organ donors, and protecting newborns from hepatitis.
Derek isn’t just lacing up his sneakers for the 2025 Falmouth Road Race—he’s on a mission to raise awareness and funds for American Liver Foundation (ALF) through this very personal Liver Life Challenge—Choose Your Challenge campaign. Read Derek's inspiring story and how he continues to keep his mother's memory alive. Read his story now.
ALF’s Liver Life Advocacy Summit was held in Washington, D.C. April 29th and 30th and brought together patients, caregivers and families from coast to coast to champion legislative priorities for liver health and help the 100 million Americans affected by some form of liver disease.
American Liver Foundation (ALF) will bring together patients, caregivers, and family members affected by liver disease from across the country for the Liver Life Advocacy Summit in Washington, D.C., on Tuesday, April 29 and 30 to champion ALF’s 2025 legislative priorities.
American Liver Foundation (ALF) is thrilled to announce the recipients of its prestigious 2024 Liver Scholar and Postdoctoral Research Fellowship Awards. […]
American Liver Foundation (ALF) and the U.S. Department of Veterans Affairs (VA) and Veteran Health Administration (VHA) are excited to announce a partnership to help Veterans who are either at risk or living with liver disease.
Event Date: February 27th, 2025 Event Time: 12:00 p.m. EST Zoom link: Please register for zoom link Join us to explore […]
American Liver Foundation applauds the Biden Administration for its proposed rule change to expand Medicare and Medicaid coverage for FDA-approved anti-obesity medications.
American Liver Foundation (ALF) is thrilled to announce that Jacquelyn J. Maher, MD, is the winner of its 2024 Distinguished Scientific Achievement Award (DSAA).
American Liver Foundation (ALF) is proud to once again be a member of the TCS New York City Marathon Charity Program, Run for Charity, for the 2024 race, which takes place on Sunday, November 3, 2024.